Details for New Drug Application (NDA): 017823
✉ Email this page to a colleague
NDA 017823 describes HALOG, which is a drug marketed by Sun Pharm Inds Inc, Westwood Squibb, and Bristol Myers Squibb, and is included in six NDAs. It is available from three suppliers. Additional details are available on the HALOG profile page.
The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the halcinonide profile page.
The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the halcinonide profile page.
Summary for 017823
| Tradename: | HALOG |
| Applicant: | Sun Pharm Inds Inc |
| Ingredient: | halcinonide |
| Patents: | 0 |
Pharmacology for NDA: 017823
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 017823
Suppliers and Packaging for NDA: 017823
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HALOG | halcinonide | SOLUTION;TOPICAL | 017823 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-0249 | 0003-0249-15 | 20 mL in 1 BOTTLE, PLASTIC (0003-0249-15) |
| HALOG | halcinonide | SOLUTION;TOPICAL | 017823 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-0249 | 0003-0249-20 | 60 mL in 1 BOTTLE, PLASTIC (0003-0249-20) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
